Utility and Patterns of C5b-9 and C4d Immunohistochemical (IHC) Staining in Thrombotic Microangiopathies (TMA)
Mustafa Al-Kawaaz, Steven Salvatore, Surya Seshan. Weill Cornell Medical College, NY, NY. Background: TMA is microvascular injury and thrombosis, often accompanied by thrombocytopenia and hemolytic anemia. Secondary TMA occurs in association with autoimmune diseases with or without immune complex deposits (ICGN), medications including chemotherapy, transplantation and other less common causes. The variability of etiologies/triggers for atypical and secondary forms of TMA and the stage of renal TMA present a diagnostic and therapeutic challenge as to the underlying pathogenetic mechanism such as complement activation. This study aims to investigate the role of C5b-9 and C4d IHC in renal biopsies with TMA.
Design: 44 patients with TMA on renal biopsy using LM, IF and EM findings. This group was divided into atypical(23) (without a secondary cause), autoimmune (ICGN) (8) and no immune complexes(6), chemotherapy related(7) categories. A control no-TMA group(8) was divided into ICGN(3) and non-ICGN(5) (2 nonrejection transplant bx) categories. Results: 44 patients (M: 18, F: 26), 2-82 years, presented with elevated creatinine (0.87-11.0mg) and moderate to malignant hypertension. All cases of TMA showed varying degrees of positive staining for C5b-9 (1-3+) within the glomeruli (G), arterioles (Ar), small arteries (SA) and peritubular capillaries (PTC) when compared to no-TMA controls cases (p=0.003-0.013). Although C4d was stronger in G in TMA (p= 0.03), no significant difference was identified in SA, Ar and PTC, when compared to no-TMA controls (p=0.66-0.18). However, all ICGN cases localized strong G staining for C5b-9 and C4d (C5b-9>C4d) . While similar intensity (C5b-9>C4d) of G was seen in all other TMA groups without ICGN, mostly negative or focally positive C4d (mainly in active TMA lesions) was noted in the Ar and SA in TMA groups other than the atypical TMA, compared to strong (3+) C5b-9 in all TMA groups (67% vs 95%). In contrast, the PTC displayed diffuse C4d + in 65% of all cases of TMA, whereas focal C5b-9 was noted in only 10% (p=0.000015), in both active and chronic TMA. Strong G staining for C5b-9 persisted in all chronic TMA cases as opposed to weaker or no staining for C4d (p=001). Conclusions: Systemic or local complement activation has been implicated in the pathogenesis of TMA and emerging therapies directed against the complement system have produced favorable clinical response. Though the distribution and staining pattern for C4d and C5b-9 are somewhat different, they suggest tissue classical pathway of complement activation in most cases of TMA and ICGN. A combination of C4d and C5b-9 IHC may aid in identification of cases with complement activation.
Apolipoprotein A-IV Amyloidosis Has a Renal Medullary Interstitial Pattern of Deposition -Report of 10 Consecutive Cases
Md Shahrier Amin, Surendra Dasari, Paul J Kurtin, Julie Vrana, Jason D Theis, Sanjeev Sethi. Mayo Clinic, Rochester, MN. Background: Apolipoprotein A-IV is a rare cause of amyloidosis. There has only been one case report of apolipoprotein A-IV amyloidosis (AAA). The aim of this study was to further characterize the clinicopathological correlates of AAA in the kidney in a bigger cohort of patients. Design: The Mayo Clinic archives were searched for cases of AAA confirmed by laser microdissection and mass spectrometry. The demographic, clinical and morphological correlates were studied in cases with renal involvement. Results: Between 2006-2014, apolipoprotein A-IV was detected as the principal amyloid in 30 patients. The organs in which AAA was detected include: kidney -10 (33%), small intestine -9 (30%), heart -8 (26%), lung -1, skin -1, both heart and kidney -1, both heart and mesentery -1. Among the 10 patients with renal biopsies, 8 were men and 2 women (M:F~4:1). Mean age at diagnosis was 64.5 years. Past medical history was significant for hypertension in 5 and diabetes in 4 patients. 2 patients complained of low back pain. Gradual decline in renal function, with rising serum creatinine (mean at time of biopsy 2.6 mg/dL) was the most common cause for biopsy; proteinuria was absent or minimal (<500 mg/day). Hematological and serological evaluation was negative. The renal biopsy showed moderate to marked quantities of amorphous, homogeneous, glassy eosinophilic deposits restricted to the renal medulla. The deposits were positive on Congo red stain and showed apple green birefringence under polarized light. Immunofluorescence studies were negative in all cases. Electron microscopy showed non-branching fibrils measuring 7-10 nm in thickness. There was no significant cellular reaction to these deposits. Other biopsy findings included mild to moderate arteriosclerosis in 5 patients, moderate interstitial inflammation limited to the cortex in 3 patients and post-infectious glomerulonephritis in 1 patient. Conclusions: This is the first case-series describing the clinical and morphologic characteristics of renal involvement by AAA. AAA presents with gradual decline in renal function and is characterized by large deposits of amyloid restricted to the renal medulla. The diagnosis may be missed if the sample does not contain medulla. A high degree of suspicion is needed to make the diagnosis of AAA that requires confirmation by laser microdissection and mass spectrometry. Further follow-up and studies are required to elucidate the outcome and appropriate management of renal-limited AAA.
not different between IgA and IgA+IgG. Analysis of renal biopsy findings (n=175) revealed no differences in Oxford score, presence of crescents, nor presence of other immunoreactants in the IgA vs. IgA+IgG groups, nor by comparing groups with C3 deposition vs. those without. Biopsies with crescents/segmental glomerular necrosis (n=65) were associated with endocapillary hypercellularity (p<0.001), and deposit location in the peripheral capillary walls in addition to mesangium (p=0.002). Conclusions: In this predominantly Caucasian population with IgAN, glomerular IgG codeposition did not affect clinical outcome.
PLA2R Negative De Novo Membranous Nephropathy Associated with Antibody-Mediated Rejection; a Report of 11 Cases with Common Light Microscopic and Ultrastructural Features
Siripron Angchuan, Mongkon Charoenpitakchai, Jittirat Arksarapuk, Agnes B Fogo, Paisit Paueksakon. Vanderbilt University Medical Center, Nashville, TN; The Queen's Medical Center, Honolulu, HI. Background: Membranous nephropathy (MN) in the renal allograft can occur either as a recurrence of primary disease or de novo. Antibodies to PLA2R have been associated with some cases of recurrent MN, but the data thus far are limited. In contrast, the pathophysiology of de novo MN is not clearly understood but may be associated with antibody-mediated rejection (ABMR) in the allograft. Design: Biopsies of 17 patients with MN in the transplant biopsy who had a tissue diagnosis/clinical history reviewed at VUMC documenting the primary native renal disease were studied. Morphologic evaluation and PLA2R staining was performed. Results: 11 pts (64%) had de novo MN and 6 pts (36%) had recurrent MN. 2/6 (33%) pts with recurrent MN showed microcirculation inflammation (MCI), in contrast to MCI in all pts (100%) with de novo MN. In recurrent MN, PLA2R was positive in 4/6 (67%) pts, in contrast to de novo MN, where none (0%) showed PLA2R positivity. C4d was positive in 1/6 (17%) pts with recurrent MN and 3/11 (27%) with de novo MN. Donor specific antibodies were positive in 1/2 (50%) pts with available data in recurrent MN and 2/3 (67%) in de novo MN. In both recurrent and de novo MN, all pts (100%) by definition showed subepithelial (SEP) deposits by EM, and IgG and C3 staining by IF. There was no evidence of transplant glomerulopathy (TGP), multilayering of peritubular capillary basement membranes (PTC), subendothelial (SEN) or mesangial (M) deposits in recurrent MN (0%). However, in de novo MN, 10/11 (91%) showed multilayering of PTC and of these; 6 (55%) showed TGP, and of these; 5 (45%) showed M and/or SEN deposits by EM. Conclusions: PLA2R staining was found in most recurrent MN patients but in none of de novo MN, supporting a distinct pathogenesis of de novo MN in the transplant. Most patients with de novo MN had MCI, PTC basement membrane multilayering, TGP, M and/or SEN deposits. These common LM and EM features support antibodymediated rejection as an underlying etiology of de novo MN. Furthermore, M and SEN deposits are new findings which have not previously been described in MN associated with ABMR, raising the possibility that circulating immune complexes may deposit on the luminal side of the GBM and in the mesangium, disassociate, and reform in a subepithelial position. We further conclude that these common LM and EM findings together with negative PLA2R are surrogate markers for MN associated with ABMR. Background: Glomerular disease is responsible for a significant proportion of endstage renal disease (ESRD) in the United States. About 10-15% of ESRD is caused by glomerulonephritis (GN), and diabetic nephropathy (DN) is the most prevalent renal disease with glomerular manifestations, accounting for over half of ESRD cases. Given that glomerular disease is the etiology for ESRD in a large proportion of renal transplant patients, glomerular disease recurrence in renal allografts is not uncommon. Determining the specific glomerular diseases that recur most frequently can help nephrologists identify patients that may require close follow-up and treatment after transplantation for disease recurrence. In this study, we retrospectively analyzed renal allograft biopsies performed at our institution from 1994 through 2015 to determine the prevalence and trends over time of various types of recurrent glomerular diseases in renal allografts. Design: Renal allograft biopsy reports were reviewed for the diagnosis of recurrent glomerular disease between 1994 and 2015 at our institution. The cases of recurrence were then stratified by diagnosis and year of biopsy, the latter of which was divided into two separate decades (1994-2004 and 2005-2015) . Results: In total, 448 cases of recurrence were identified out of 6850 allograft biopsies (6.5%). Between 1994 and 2004, 159 cases of recurrent disease were identified out of 862 allograft biopsies (18.5%), while 289 of 5988 allograft biopsies were found to have recurrent disease from 2005 to 2015 (4.8%). The most common recurrent diseases included focal segmental glomerulosclerosis (FSGS; 36%), IgA nephropathy (25%), DN (13%), membranoproliferative GN (MPGN; 7%), and membranous GN (6%). Comparing 1994 Comparing -2004 Comparing to 2005 Comparing -2015 , the proportion of recurrent cases showing FSGS decreased (42% vs. 34%) while those with DN and MPGN increased (9% vs. 14% and 3% vs. 7%, respectively) , although these trends did not reach statistical significance.
Prevalence of Glomerular Disease Recurrence in Renal Allografts

Conclusions:
The overall frequency of renal allograft biopsies that showed recurrence has decreased over time at our institution, likely due to a drastic increase in protocol biopsies (i.e. routine biopsies performed not triggered by clinical cause). However, a sizeable proportion of renal allograft biopsies showed glomerular disease recurrence with FSGS being the most common. Comparing biopsies performed in 1994-2004 and 2005-2015 , the proportion of recurrent cases showing specific categories of glomerular disease demonstrated no statistically significant differences, although some trends were noted.
Membranous Glomerulonephritis with Monotypic IgG Deposits: A Clinico-Pathological Analysis of 28 Cases
Alejandro Best Rocha, Christopher Larsen. Nephropath, Little Rock, AR. Background: Membranous glomerulonephritis (MGN) is the most common cause of nephrotic syndrome in Caucasian adults. While the majority of cases are caused by polytypic deposits, cases with light chain restricted IgG deposits may be rarely seen. Monotypic IgG deposition in the setting of proliferative glomerulonephritis is well described in large case series and has been shown to not have an underlying lymphoproliferative disorder (LPD) in most cases. However, the significance in light chain restricted MGN is yet to be determined. We present a series of 28 cases of glomerulonephritis with a predominantly membranous pattern and monotypic IgG deposits. Design: A retrospective analysis with clinico-pathological correlation was performed of all cases of MGN with monotypic IgG deposits diagnosed at our institution between 01/2010 and 09/2015. Results: A total of 28 biopsies from 26 patients were reviewed. The mean age at diagnosis was 63.1yr (37-87yr) and the male to female ratio was 1. All patients presented with proteinuria (69.2% in nephrotic range) and the mean serum creatinine was 1.44 mg/dl (0.4-5.0 mg/dl). Histologically, all cases showed predominantly a membranous pattern, with 4 (14.3%) showing focal endocapillary proliferation with or without crescents. Kappa light chain restriction was seen in 24/28 of the biopsies (85.7%), while the remaining 4 showed lambda restriction. IgG subclasses performed in 17/28 cases showed monoclonality in 13 and biclonality in 4 (see table) . PLA2R was positive in 6/25 cases. IgG subclasses were available in 3 of the PLA2R positive cases, all of which were biclonal. Follow-up data was available in 17/26 patients. Five patients had or developed a clinical diagnosis of a LPD (predominantly CLL) and one of an autoimmune disorder. Only one patient with LPD had a detectable paraprotein, consistent with the phenotype of the glomerular deposits. 3/5 patients with LPDs had focal endocapillary proliferation, one of them with cellular crescents. None of the patients were positive for hepatitis C, and only one was positive for hepatitis B.
Monoclonal (n=13)
Biclonal (n=4) Background: Tubular elements in the renal biopsy undergo a complex synchronous process of hypertrophy, atrophy and cyst formation. The shape shifts generated are diverse and difficult to categorize and quantitate using conventional microscopy. We present three-dimensional constructs developed from such tubules. A biopsy from a patient with lithium nephrotoxicity was chosen because of the full representation of these changes. Design: The renal biopsy was serially sectioned and stained (H&E, PAS, Jones, trichrome, CD31, AE1/AE3-CAM5.2), digitized (Philips UFS) and the sequential whole slide images (WSIs) viewed on https://slide-atlas.org. Serial WSIs were aligned, and the regions of interest segmented, extracted and volume-rendered for further analysis.
Results: Typical changes of lithium toxicity were seen: cysts, tubular atrophy and hypertrophy. All these changes were all more easily appreciated by rapid sequential viewing of aligned WSIs. 3D volumes of selected larger cysts, and groups of hypertrophic or atrophic tubules were generated and compared with respect to their relative size and shapes ( Figure 1 ). Estimated volumes of the larger cysts were 10-fold greater than those of the hypertrophic tubules, which in turn were 10-fold greater than those of the atrophic tubules. Conclusions: These studies show a wide range of shape shifts in tubular elements. Representation of actual cyst size within the renal parenchyma can be calculated. These studies are the first of this type and serve to advance the better understanding of chronic renal disease.
Capsulitis: A Novel Histologic Correlate in T-Cell Mediated Rejection
Alexander J Gallan, Kammi J Henriksen, Anthony Chang. The University of Chicago, Chicago, IL. Background: Acute T-cell mediated rejection (TCMR) is an important cause of renal allograft loss. The Banff schema classifies TCMR based on the degree of lymphocytic infiltration of the tubules (types IA and IB) and arteries (types II and III), which correlates with allograft function and survival. However, lymphocytes can also occasionally be identified on the intraglomerular aspect of Bowman capsules (or "capsulitis"), which has not been previously described. This study was undertaken to define the novel histologic feature of "capsulitis" and delineate its clinicopathologic relevance in TCMR of kidney allografts. Design: We identified renal biopsies with TCMR at our institution from 2010-2015. Exclusion criteria included repeat biopsies from the same patient, presence of <7 glomeruli, and concomitant polyoma virus nephropathy. The cases were assessed for capsulitis, defined as the presence of one or more lymphocytes between Bowman capsules and parietal epithelial cells in a single non-globally sclerosed glomerulus. The 2013 Banff classification was applied. Clinicopathologic variables were compared using Chi-square test.
Results: A total of 72 cases of TCMR were identified. There was no significant difference in age, sex, graft age, or serum creatinine level at time of biopsy between the cases with and without capsulitis. Capsulitis could occur mechanistically as an ascending progression of tubulitis through the urinary pole and into Bowman capsule. However, we also identified capsulitis in isolated Banff II and III cases, and noticed type IA cases with capsulitis and ischemic fraying of Bowman capsules. This raises the possibility of a second potential mechanism of direct penetration of lymphocytes despite the increased thickness of Bowman capsule compared to the tubular basement membrane.
Conclusions:
This study describes a novel histologic feature of "capsulitis" in TCMR of renal allografts. We found that capsulitis was more commonly associated with Type IB than IA TCMR, suggesting that capsulitis may be a marker for more severe TCMR. Additional studies are necessary to further delineate the pathologic and clinical relevance of "capsulitis" in acute TCMR of renal allografts.
Routine Clinical Use of Exome NGS for Diagnosis in Patients with Renal Disease
Joseph Gaut, Sanjay Jain, John D Pfeifer, Catherine E Cottrell. Washington University, St. Louis, MO. Background: The state of the art in renal pathology relies on light, immunofluorescence, and electron microscopy (LIEM). However, in selected patients, this combination of techniques is insufficient to make a firm diagnosis. Since a subset of renal diseases (e.g. nephrotic syndrome, atypical hemolytic uremic syndrome (aHUS), cystic diseases) are increasingly recognized to harbor genetic mutations responsible for the disease or that serve as disease risk factors, next generation sequencing (NGS) as part of routine clinical practice has potential to increase diagnostic accuracy. Design: Cases for which the results of traditional LIEM analysis were not definitive were referred for germline NGS sequencing as part of routine patient care (via exomebased DNA sequencing using a hybrid capture approach, and an Illumina HiSeq2500 with paired 2x101bp reads). Sequence analysis included 25 genes associated with the following diagnostic groups: aHUS, nephrotic syndrome, Alport syndrome, and metabolic disorders. The NGS was performed in a CAP accredited/CLIA licensed clinical laboratory, and the results were reviewed by a board certified molecular pathologist/geneticist prior to release to the patient's medical record.
Results: To date, NGS has been performed as part of routine clinical care in 23 patients referred for aHUS evaluation and 3 referred for nephrotic syndrome. Of the aHUS patients, identified sequence changes include 7 single nucleotide variants (1 novel pathologic variant in CFH and 6 variants of unknown significance (VUS) in CFH, CFI, CFB, C3, and THBDx2) and 8 indels (heterozygous deletions in CFHR3/CFHR1 in 4 patients and homozygous deletions in CFHR3/CFHR1 in 4 patients). Of the nephrotic syndrome patients, 2 single nucleotide variants were identified (VUS in LAMB2 and ACTN4), but all cases were negative for APOL1 risk alleles. In order to support identification of associations between identified sequence variants and pathogenesis in cases for which traditional LIEM is not definitive, a registry of all referred cases has been established. Conclusions: VUS represent the largest category of identified genetic variants among patients with aHUS and nephrotic syndrome. Thus, elucidation of disease associations between sequence variants in cases for which traditional LIEM is not definitive will require correlation of NGS results with other genetic, phenotypic, and clinical parameters. Partnerships among groups that perform NGS sequencing as part of routine clinical care will help to rapidly expand this database.
Spectrum of Glomerular Lesions in Native Renal Biopsies with TRIs
Rajib Gupta, Serena Bagnasco, Naima Carter-Monroe, Lois Arend. Johns Hopkins University, Baltimore, MD. Background: Tubuloreticular inclusions (TRIs) are small clusters of anastomosing tubule-like structures most commonly found in the cytoplasm of endothelial cells. They suggest elevated interferon levels associated with viral infection, autoimmune disorder, or rarely drugs (most commonly interferon therapy). We present a 10-year study of the prevalence of TRIs in glomerular diseases from all native biopsies received. Design: Native kidney biopsies from 2005 to 2015 were reviewed for presence of TRIs. The biopsies were divided into lupus (sub-divided into established lupus, past history of lupus, or suspicious for lupus), viral infections (sub-classified into HIV, HCV, HBV, or a combination) and an "other" category.
Results: 250 cases were found with TRIs. 126 cases fell into one of the lupus subcategories (50%), 68 cases had one or more of the 3 viral etiologies (27%), and 56 belonged to the other category (22%). Among the 126 lupus cases, 97 were established lupus cases, 22 were suspicious for lupus, and the remaining 7 were patients with a past history of lupus. Biopsies with Class III, IV, and V had the highest prevalence of TRIs. In the infectious category of biopsies with TRIs, 26 cases had HIV, 22 cases had hepatitis C, 16 had both HIV and HCV, one case had both HCV and HBV, and 1 case was positive for all 3 viruses. In the other category, multiple myeloma was present in 5 cases; minimal change disease was present in 7 cases, 7 cases had diabetic nephropathy, 10 cases had focal segmental glomerulosclerosis, 3 cases had an autoimmune connective tissue disorder other than lupus, most commonly rheumatoid arthritis; 5 cases had membranous nephropathy, 3 were IgA-dominant post-infectious glomerulonephritis, 3 cases were ANCA-associated glomerulonephritis, 1 case had a diagnosis of Alport syndrome and 1 other was suspicious of Alport, 1 case of hypertensive renal vascular disease, 1 case each of thrombotic microangiopathy and Henoch-Schonlein purpura, and 4 cases were idiopathic. Conclusions: TRIs are an electron microscopic feature found in a variety of glomerular diseases. While they appear when interferons are elevated for various reasons -infection, immune dysfunction, exogenous interferon therapy, or drug-induced increase in interferon level, they are found in numerous settings not typically associated with high levels of interferon, which may indicate an as yet unknown pathogenesis. In this study, we evaluated DC subtypes, markers of endothelial activation, and Th subsets by immunohistochemistry (IHC) in renal transplant biopsies with the hypothesis that DC populations are differentially upregulated in antibody-mediated rejection vs. controls. Further, we studied the association of intragraft DC subtypes with endothelial activation and FOXP3/STAT3 ratio. Background: Scattered studies using quantitative real-time PCR (qPCR) for BKV in renal tissue suggest feasibility of the technique for detecting BKV, however, no clinical utility of qPCR for BKV using renal tissue has been implemented. When SV40 staining is negative in a biopsy while the patient has high serum or urine BKV, it is a dilemma how to give an accurate diagnosis and to treat the patient. This investigation was to determine whether qPCR from paraffin embedded tissue could enhance the detection of BKV in renal grafts biopsies with negative SV40 staining. Design: Thirteen negative controls (4 tonsils, 2 native kidney biopsies, 7 renal transplant biopsies with 3 acute tubular injury, 3 acute cellular rejection and 1 antibody mediated rejection), 5 positive controls (1 bladder biopsy, 4 renal graft biopsies with known positive SV40 staining) and 5 uncertain cases (high clinical suspicion with high urine/ serum BKV and negative SV40 staining) were selected for the study. DNA was extracted from each specimen using five 5-µm curls from the formalin-fixed parafin-embedded tissue block using the QIAamp DNA FFPE Tissue Kit (Qiagen) for BKV qPCR (The qPCR linear range is 500 to 500 x 10 6 copies/mL).
Dendritic Cells in Renal Allografts
Results: BKV was not detected in the tonsillar and native kidney biopsies. BKV was detected (10 copies/ng DNA) in the negative control renal transplant biopsies. Except one positive case with minimal renal tissue left showing 2.5 copies/ng DNA, the remaining 4 positive cases had high pairs of BKV ranging from 5,263 to 160 million copies/ng DNA. In five uncertain cases, there were low BKV levels, ranging from 160 to 277 copies/ng DNA in 3 cases with rejection diagnosis in the reports (low suspicion), but 0.19 to 0.53 million BKV copies/ng DNA in the remaining two cases (high suspicion).
Conclusions: Our data demonstrate that qPCR BKV testing from paraffin embedded tissue is very sensitive for ruling in/out BKV in renal transplant biopsies. Based on our preliminary data, cut-off values of < 10, 10 to 500 and >500 copies/ng DNA may represent absence, low suspicion and high suspicion for the presence of BKV in biopsies, respectively. Isaac Lloyd, Hunter Huston, Stephen Jenkins, Kalani Raphael, Dylan Miller, Monica P Revelo, Mazdak Khalighi. University of Utah, Salt Lake City, UT. Background: C3 glomerulopathy (C3GP) includes both C3 glomerulonephritis (C3GN) and dense deposit disease (DDD) and is defined by C3-dominant deposits by immunofluorescence. Abnormal function of the alternative pathway (AP) of complement is central to the pathophysiology of C3GP and young patients often harbor genetic alterations of mediators of AP. Recently, a link between C3GP and paraproteinemia has been established, but the frequency of this association in older patients is not well characterized. To explore this, we studied C3GP specifically in adults > 50 years in age. Design: 13 biopsies from 11 patients meeting diagnostic criteria for C3GP were identified in patients over the age of 50 from 2005-2015. Pathologic and clinical features were reviewed, including the presence of a monoclonal gammopathy and/or lymphoma or plasma cell dyscrasia. Results: C3GP accounted for 1.8% of biopsies in patients > 50 years during the study period. 73% of patients were male and the median age was 63 (range: 52-90) years. The mean serum creatinine at presentation was 2.75 (range: 1.2-10) mg/dL and mean proteinuria was 3.1 (range: 0.1-10) g/day. Hematuria was universally present. A paraprotein was identified in 8 patients (7 IgG-κ, 1 IgG-λ) and 1 additional patient was diagnosed with classical Hodgkin lymphoma 6 months prior to diagnosis of C3GN. Of the patients with paraproteinemia, 3 had myeloma on bone marrow biopsy, 2 had monoclonal gammopathy of undetermined significance (MGUS), and 1 had a polyclonal plasmacytosis. On kidney biopsy, 9 showed MPGN, 3 showed mesangioproliferative GN, and 1 showed a focal exudative GN. Ultrastructural findings diagnostic of DDD were seen in 1 patient with MPGN and 1 with mesangioproliferative GN. The biopsy showing focal exudative GN represented recurrent disease in an allograft. Mean follow up was 3.1 years (range: 1 month-10 years). 5 patients required chronic renal replacement therapy (RRT), 1 of which passed away soon after the diagnosis of C3GP and Hodgkin disease. 5 patients had stable chronic kidney disease (CKD) at last follow-up. 1 patient, who presented with acute kidney injury, underwent bone marrow transplant for multiple myeloma and had baseline kidney function one year post transplant. Conclusions: C3GP is an uncommon but important cause of kidney injury in older adults as 45% of patients in our cohort required RRT and all but 1 had CKD at followup. Given that over 80% of patients demonstrated a monoclonal gammopathy (of renal significance), myeloma or lymphoma, the presence of C3GP in this population should prompt hematologic evaluation.
C3 Glomerulopathy in Older Adults
Quantitative Assessment of Density of Deposits in C3 Glomerulopathies
Mark Lusco, Agnes B Fogo. Vanderbilt University Medical Center, Nashville, TN. Background: C3 glomerulopathy (C3GP) includes a range of diseases from C3 glomerulonephritis (C3GN) to dense deposit disease (DDD), all with C3 dominant deposits and an etiology of alternative complement pathway dysregulation. C3GN is distinguished from DDD by location and perceived density of deposits on electron microscopy (EM). In some cases, intermediate deposit density causes difficulty in distinguishing these entities. We quantitatively assessed the density of C3 deposits to objectively characterize the spectrum of deposits in C3 glomerulopathy.
Design:
We identified all renal biopsies at Vanderbilt University from January 2011-July 2015 with diagnosis of DDD or deposits with at least 2+ greater intensity for C3 than other complement or immunoglobulin by immunofluorescence (IF). Only biopsies with distinct glomerular deposits by IF with corresponding deposits on EM were included. Assessment of density (black content) in deposits, red blood cells (RBC) and glomerular basement membranes (GBM) was performed using Adobe Photoshop from 8-bit grayscale digital photographs or scanned prints. Within the same photograph, deposits, uninvolved GBM and RBC were included to ensure equal photographic exposure. The most frequent type, densest and most diagnosis-defining deposits were assessed. Density was determined by normalizing the black content on a scale of 0-100 based on the black content of uninvolved GBM (0) and RBC (100), thus, allowing comparison of density scores in different images and cases. In addition, 9 usual type immune complex glomerulonephritis (UTICGN) cases were assessed. Results: 61 cases of C3GP were identified, and 3 lacked EM images or grid availability and thus were excluded. DDD (n=7) had the highest normalized density score, mean 91 (range 71-100). 3 cases with a diagnosis that included features of DDD had a density score mean 76 (71-81). Proliferative GN or post-infectious GN with dominant C3 (n=24) had deposit density score mean 60 (range 25-100). All other C3 dominant deposit cases (n=24) had a similar density score mean 60 (range 25-100). UTICGN control cases overall had lower density score with mean 54 (range 21-100).
Conclusions:
The measurement of deposit density decreases as expected from DDD to UTICGN. C3GN cases showed similar density to UTICGN. Cases with features suggestive of, but not diagnostic of DDD, were objectively confirmed to show intermediate density of deposits. Thus, the measurement of characteristic EM deposit density may be a helpful guideline for characterizing disease with C3 dominant deposits.
Renal Allograft Biopsy CD3+ Cell Quantitation Algorithm Development for Rejection Assessment Utilizing Open Source Image Analysis Software
Andres Moon, Geoffrey Smith, Thomas E Rogers, Carla L Ellis, Alton B Farris. Emory University School of Medicine, Atlanta, GA. Background: Renal allograft rejection diagnosis depends on assessment of parameters such as interstitial inflammation; however, studies have shown wide interobserver variability. Commercial cell counting algorithms are currently available, with data suggesting correlation between densities of CD3 staining with severity of T-cell mediated rejection. Image analysis and automated quantitative methods may prove potentially more reproducible; therefore, we devised customized methods of analysis and compared these with established commercial methods along with visual assessment. Design: Renal allograft biopsies with varying degrees of rejection were retrieved (n = 30), and CD3 immunohistochemistry slides were scanned to obtain whole slide images (WSIs). Inflammation was quantitated in the WSIs using pathologist visual assessment, commercial algorithms (Aperio nuclear algorithm to give CD3/mm 2 and Aperio positive pixel count algorithm), and customized open source algorithms developed in ImageJ which involved thresholding/positive pixel counting (Calculated CD3/mm 2 ) and identification of pixels fulfilling "maxima" criteria for CD3 expression (Custom CD3/mm 2 ). Results: CD3 quantitation algorithms correlated between each other and also with visual assessment in a statistically significant manner (Fig 1) . Methods for assessing inflammation showed a progression through the grades of tubulointerstitial rejection, with statistically different results in borderline versus other rejection cases (Fig 2) , in all but the custom CD3 count method.
Conclusions: Assessment of CD3-stained slides using various open source image analysis algorithms shows correlation with established methods of CD3 quantitation.
These analysis techniques are promising and highly customizable, providing a form of on-slide "flow cytometry" that may facilitate additional diagnostic accuracy in the assessment of patient material. We assessed the predictive role of non-neoplastic renal pathology in a cohort of patients with normal pre-operative renal function who underwent radical nephrectomy for a renal mass. Design: All local patients with a normal contralateral kidney who underwent radical nephrectomy between April 2002 and May 2008 were identified. Patients with missing clinical data or pre-operative chronic kidney disease (CKD), defined as Glomerular Filtration Rate (GFR) <60mL/min/1.73m 2 ) were excluded. Pathology slides were rereviewed by genitourinary pathologists (MM&MG) for presence of Glomerulosclerosis (GS), Interstitial Fibrosis (IF), Tubular atrophy (TA), and arterial narrowing (AN) which were correlated with pre and post-op renal function. Student's t test and logistic regression were used to assess statistical significance. Results: Ninety seven patients met inclusion criteria and had tissue available for pathology review. GS, IF, TA and AN was present in 70%, 44%, 44% and 96% of patients, respectively. The presence of IF and TA was associated with relatively reduced renal function both pre-op and at 1 year. Patients with GS demonstrated significant decline in renal function at 1 year despite normal pre-operative renal function. Of the assessed clinical conditions, only hypertension and coronary artery disease were associated with poor post-op renal function on logistic Regression (p=0.04 and 0.04). 
Conclusions:
Evaluation of non-tumor renal tissue at the time of radical nephrectomy offers valuable predictive information regarding post-operative renal function. Significant pathological findings were common in our patient cohort. Our data suggest an ongoing role for pathological evaluation of non-neoplastic renal tissue in nephrectomy specimens. The overall impact of pathological evaluation needs to be evaluated in a larger cohort using multi-variable analysis. (n=30) were also associated with GBM-C4d.
Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Is a Common Form of Renal Amyloidosis Among Egyptians
Stepwise exclusion and multivariate logistic regression showed significant correlations between architectural GBM changes with duplications and GBM-C4d staining corrected for peritubular capillary C4d deposits and antibody mediated rejection (p=0.001). Native control biopsies with chronic thrombotic microangiopathy showed GBM-C4d in 92% by IF, p<0.001, and 35% by IHC; no GBM-C4d present in minimal change disease.
Conclusions:
The significance of GBM-C4d differs from C4d staining along peritubular capillaries. Pseudolinear GBM-C4d reflects two forms of injury: 1) thrombotic microangiopathy like structural changes with GBM duplications independent of a specific etiology/antibodies, or 2) active antibody mediated rejection characteristically accompanied by C4d along peritubular capillaries and spill-over GBM-C4d. The detection of strong, especially isolated pseudolinear GBM-C4d could optimize a diagnosis and potentially has therapeutic implications. Results: 7 ANL patients were ANA and DS negative. 11 ANL patients had 'full house' staining, none had tubular deposits, 6 had subepithelial, subendothelial and mesangial deposits, and none had TRIs. Two ANL and one control group case had positive PLA2R by IF. In the study group, 23% had poor renal outcomes vs. 27% in the control group, creating a relative risk of 0.85 (Fisher exact test p = 0.77).
ANA is an unreliable screening test for SLE, and DS can also be negative in RLL. Pathologists should therefore have a lower threshold for diagnosing LN in patients with limited serology. Rare cases of ANL and APL have IF PLA2R positivity; this may be less specific for primary membranous nephritis than previously believed. This study suggests that renal outcomes in ANL are equivalent to those in conventional LN, supporting lupus-specific treatment of RLL. 
Hypoxia in Human Renal
Background:
The conditions for demonstrating hypoxia in human renal disease are complicated, because oxygen utilization is more limited in the injured parenchyma (reduction of transport). The most valid marker of hypoxia is HIF 1 alpha, which degrades very quickly, but has been shown to be present in biopsies taken immediately after transplantation (J Am Soc Nephrol. 2007; 18(1):343-51). However, its closely allied gene target CA 9 persists for at least 96 hours after a normoxic environment is established (Biochim Biophys Acta. 2009; 1795(2):162-72).
Design: We present a series of 42 biopsies stained for CA 9: 4 groups were examined, 3 chosen because of a putative acute hypoxic element: delayed graft function (9); native AKI, commonly with an element of CKD (13); vasculopathy (10) including TMA (2), ANCA (6), malignant hypertension (1) and cryoglobulinemia (1). A fourth group represented chronic renal disease (10) and included IgA nephropathy, diabetes or chronic allograft nephropathy. Controls were nephrectomies and biopsies of failed transplants (3). Staining was graded on a 0-4+ scale; X +/-SE were calculated from positive cases. Results: With near-total renal infarction, the renal capsule is viable and the subjacent renal parenchyma shows extensive up regulation of CA9, both in regenerating tubules and the capsule. Staining in the biopsies, when limited, was usually luminal. Increased staining ranged from luminal to complete tubular (proximal and/or distal) involvement. With more intense staining, podocytes, crescents and Bowman's capsular epithelium were also positive. Biopsies with pure delayed graft function were usually negative, except for two patients, one with a large compressing hematoma and another with recurrent FSGS. Native ATN cases (score 1.75 +/-0.5) and vasculopathy cases (score 2.1 +/-0.5) were 50% and 70% positive, respectively. The most intense staining was seen in the vasculopathy group, but the differences between the two groups were not significant. Chronic renal disease staining was essentially negative.
Conclusions: Hypoxia can be demonstrated in human renal disease, often when a vasculopathy is present. Uncomplicated delayed graft function and chronic kidney disease are generally negative. In AKI occurring in native kidneys, a hypoxic element can be shown and suggests ongoing active injury, in spite of diminished transport. This is the first study to provide evidence of hypoxic injury in a spectrum of renal diseases.
The Pathology of 'Pure' T-cell Mediated Rejection in the Era of C4d Staining and Testing for Donor Specific Antibodies
Parmjeet Randhawa, Gang Huang, Simrath Randhawa, Gang Zeng, John Lunz, Xiaomu Zhao. The Thomas E. Starzl Transplant Institute, Pittsburgh, PA. Background: Recent literature has stressed the prominent role of antibodies in acute and chronic graft loss. This study was designed to assess a growing perception that T-cell mediated rejection (TCMR) is no longer clinically relevant. Design: 545 renal allograft recipients over a 3 year period were screened for biopsies satisfying the following criteria: (a) TCMR including borderline change (BL), (b) negative C4d stain, and, (c) absence of DSA at time of transplant, within 30d of the biopsy, and up to 4 measurements at later time points. Control renal allograft biopsies (n=14) were selected from the same time period as the study cases based on similar criteria, but with no evidence of TCMR, BL, antibody injury, C4d staining, infection, thrombotic microangiopathy, or glomerulonephritis.
Results: These stringent requirements led to the identification of 18 cases of 'pure' TCMR and 10 BL cases. Interestingly, glomerulitis which is used as diagnostic criterion for ABMR was present in 1/10 BL biopsies (g=1) and 5/18 TCMR biopsies (g=1). Peritubular capillaritis was demonstrable in 1/10 BL biopsies (ptc score 1) and 8/18 TCMR biopsies (ptc scores 1 and 2 in 3 and 5 biopsies respectively). Chronic transplant glomerulopathy, another lesion said to be characteristic of chronic ABMR, was found in 1/10 BL biopsies (cg =1) and 3/18 TCMR biopsies (cg=1, 1, 3). Intimal arteritis (v=1) was found in 1/10 follow up TCMR biopsies. Serum creatinine showed complete short-term remission in 7/10 (70%) BL and 9/18 (50%) in TCMR patients 1m post-biopsy. Yet, both treated and untreated patients demonstrated further decline in graft function as assessed by serum creatinine and estimated GFR. Conclusions: TCMR can cause significant deterioration of graft function in patients with TCMR in whom the dominant contribution of antibody mediated injury has been reasonably excluded Our data also reinforces existing literature showing that microvascular lesions do not have absolute specificity for a diagnosis of antibody mediated rejection. Adam Robin, Colin C Hansen, Lauren Parsons, Christopher Hartley, Eric Cohen, Alexander C Mackinnon. Results: Fourteen (34%) of the 41 cases showed loss of GBM staining for COL4A5, including 9 with concurrent loss of staining of Bowman's capsule (BC) and distal TBMs (consistent with X-linked AS, 3 were brothers) and 5 with preserved staining of BC and distal TBMs (consistent with autosomal AS). Compared with the 27 patients with preserved GBM staining for COL4A5, the 14 with loss of staining were younger (mean age at biopsy 14 vs. 27 yrs, p<0001), mostly males (86% vs. 41%, p=0.004), had higher incidence of hearing loss (58% vs. 16%, p=0.01), less global GS (5% vs. 18%, p=0.02) and more prominent GBM ultrastructural alterations (marked grade in 79% vs. 14%, p<0.001; mild in 0% vs. 59%). The degree of proteinuria or interstitial fibrosis and the presence of renal insufficiency, HTN, segmental sclerosis, foam cells, or family history of hematuria were not statistically different between the 2 groups. Conclusions: Loss of GBM staining for COL4A5 correlates with younger age at diagnosis and more severe GBM ultrastructural alterations, likely reflecting larger genetic mutations in these patients. IF staining for COL4A5 is useful to predict the severity of genetic defects and to determine the mode of inheritance. In AS cases showing only mild/segmental GBM splitting, staining for COL4A5 is not helpful to confirm the diagnosis nor to distinguish AS from thin basement membrane nephropathy. 
Renal Cell Carcinoma in Allograft Kidneys: Use of Short Tandem Repeat Analysis to Determine Donor Origin of Cancer
Conclusions:
We conclude that endocapillary hypercellularity in IgAN is largely a product of glomerular macrophage infiltration and that maximum glomerular macrophage number in CD68-stained sections is an alternative to subjective E score. Background: Using mesenchymal stem cells (MSCs) to repair the injured mesangium is a rather novel concept. Previous observations from our laboratory have shown that MSCs migrate to the damaged mesangial areas and phagocytose apoptotic mesangial cells (MCs), debris and excess matrix to repair the injured mesangium. The present study aimed at finding factors to accelerate the repair process and to figure out the mechanisms involved. Design: Mesangial cells (MCs) were cultured as a single layer in 96-well plates (2D) and on Matrigel (3 and 6D). MCs after becoming confluent were made quiescent for 48 hours. Then, they were incubated with glomerulopathic light chains (GLCs) (10 ug/ml) purified from the urine of patients with renal biopsy-proven light chain-related amyloidosis (AL-Am) (n=3) and light chain deposition disease (LCDD) (n=3) for 4 days and subsequently labeled MSCs were added. TGF-β, PDFG-β, retinoic-acid and curcumin were added in the medium in different concentrations and timeframes to observe whether the repair process was altered. Samples were collected 10 days after the introduction of the MSCs (day 14) and processed for light and transmission electron microscopy. In addition, sequential photos were taken with the aid of the 6D Life Cell Imaging System. Results: MCs revealed evidence of direct damage by the GLCs including apoptosis with apoptotic bodies released and formation of amyloid or accumulation of matrix, depending on the LC used. MSCs identified and migrated to areas where damage was present. When MSCs became activated they acquired a "macrophage" phenotype. They then became active in phagocytosing cell debris, apoptotic bodies and damaged extracellular matrix. After performing this function, they proceeded to differentiate into mature MCs. Curcumin enhanced the migration of MSCs to the damaged sites and stimulated the apoptotic process. PDFG-β acted as a proliferative factor for the residual MCs and MSCs while TGF-β increased new matrix deposition. Background: Cancer remains a major cause of morbidity and mortality. The strain A/J mouse has been utilized for decades as a sensitive lung tumor bioassay model to determine relative carcinogenicity of various chemicals. This mouse is sensitive to carcinogens and if exposed, can develop multiple lung tumors that can be enumerated to determine the relative carcinogenicity of a specific chemical. More recently, the strain has been used to determine the efficacy of putative chemoprevention agents to inhibit lung tumor development. Several chemical carcinogens have been used in these chemoprevention bioassays including benzo(a)pyrene, methylnitrosourea and ethyl carbamate (EC, urethane) for eg. A metabolite of EC is vinyl carbamate (VC), also a potent carcinogen. Vinyl carbamate occurs naturally in fermented foods and alcoholic beverages; it has been reported to induce human cancers in lung, skin, liver, mammary gland and lymphoid tissues. We report unexpected findings from a chemopreventive bioassay using VC to induce lung tumors.
Design:
The experimental design of a bioassay to investigate the efficacy of potential chemopreventive agents utilized 5-6 weeks old female strain A/J mice. They were administered VC at 60 mg/kg, a dose established in the literature, via intraperitoneal injection to induce lung tumors. The experiment utilized multiple groups of animals with 47 vehicle control animals and 279 mice given the carcinogen. Mice were scheduled to be sacrificed at various time points beginning at 5 weeks through 24 weeks post carcinogen treatment to evaluate lung tumor multiplicity. Results: At 5 weeks post treatment, mice had evidence of a moribund state; these mice were killed and total necropsy was performed. At 12 weeks post treatment, a total of 97 of the 279 treated mice (37.8%) had died or were killed. Necropsies of mice that were moribund had been injected with 60 mg/kg VC were found to have developed membranoproliferative glomerulonephritis (MPGN). Control animals showed no evidence of renal disease. Conclusions: Although VC has been successfully used to induce mouse lung tumors with no reported side effects, we found profound and unexpected renal disease associated with the chemical. The etiology of MPGN has been associated with immune complex-mediated conditions, autoimmune diseases, chronic infections (Hep C), chronic microangiopathies, and malignant neoplasms like lymphoma,carcinoma etc. As VC is known to occur naturally in human diets, could exposure in some foods be a risk factor for MPGN in humans? This model may be fruitful for potential research studies of MPGN. Background: Total inflammatory load (TIL) is an important variable for the pathologic assessment of transplant kidney biopsies (TxBx). However, estimation of TIL using conventional light microscopy is suboptimal. The objective of our study was to validate a CD45 immunohistochemical (IHC) assay combined with whole slide imaging (WSI) and computer-assisted quantitative image analysis (QIA) with the future goal of standardizing the estimation of TIL in TxBx. Design: Transplant kidney biopsies with normal morphology (NL), borderline change (BL), and acute cellular rejection (ACR) were enrolled into the study. From each case, 2 serially cut 3um-thick sections were stained for CD45 on a Leica Bond RX platform using standardized IHC on consecutive days. Whole slide digital images generated on an Aperio platform were analyzed using Definiens Tissue Studio 4.1 software for CD45 IHC signal. Linear regression analysis was used to assess the repeatability of the assay performed on separate days.
Results: The quality of two sections was suboptimal and therefore only 41 cases were analyzed [NL (n=14 pairs); BL (n=16 pairs) and ACR (n=11 pairs)]. Linear regression analysis showed 95% confidence intervals for separate day processing with a slope of 0.991986 (y-intercept = 0.017405, and R 2 = 0.9951).
Conclusions:
The results demonstrate high degree of repeatability for the CD45 IHC with the aid of computer-assisted image analysis in TxBx. The assay with standardized staining, scanning and image analysis protocols can be used in future studies to assess the utility of precise TIL measurements in TxBx. Background: Molecular diagnostics have the potential to improve the classification and activity staging of native kidney diseases. The NanoString nCounter gene expression platform is unique in its ability to use formalin-fixed paraffin-embedded (FFPE) tissue samples, and represents a potential method for routine molecular diagnostics in renal pathology. We aimed to utilize this platform to assess the validity of gene expression quantification in crescentic glomerulonephritis (GN) in FFPE native kidney biopsies. Design: A literature-derived gene set for glomerular and nephron injury was generated including 54 transcripts related to podocytes, endothelial cells, M2 macrophages, NK cells, and inflammation pathways. RNA was isolated from 332 FFPE native kidney biopsies, including 225 with crescentic GN, 81 with non-crescentic proliferative immune complex GN (e.g. IgA, post-infectious, SLE, membranous), and 26 with non-crescentic non-proliferative glomerular diseases (e.g. minimal change, hypertension, diabetes). Gene set expression was quantified with NanoString and correlated with histology. Results: Gene set expression was higher in cases with crescentic GN than non-crescentic proliferative immune complex GN (p<0.001) and non-crescentic non-proliferative glomerular diseases (p<0.001). There were no statistically significant differences in gene set expression between the two non-crescentic groups (p=0.125) nor among the eight entities with crescentic GN (p=0.15-0.96). Gene set expression correlated with the degree of interstitial fibrosis and tubular atrophy (r=0.34, p=0.001). Genes associated with nephron injury correlated with the proportion of crescentic glomeruli (r=0.39, p<0.001), including cellular (r=0.24, p=0.002), fibrocellular (r=0.31, p<0.001), and fibrous (r=0.18, p=0.02) crescents.
Molecular Diagnostics for Glomerulonephritis in
Conclusions:
Our results demonstrate the feasibility of robust multiplexed gene expression quantification from archival FFPE native kidney biopsies. Measurement of a literature-derived gene set with the NanoString platform provides additional diagnostic information that may allow for more precise classification and risk stratification of patients with crescentic glomerulonephritis.
Immunotherapy Mitigates Racial Disparities in Lupus Nephritis Outcomes
Parker Wilson, Michael Kashgarian, Gilbert Moeckel. Yale University School of Medicine, New Haven, CT. Background: Lupus nephritis (LN) is a major contributor to morbidity and mortality in systemic lupus erythematosus. African Americans (AA) have a higher risk for progression to ESRD, which has been attributed to socioeconomic status, disease severity, and genetic differences. Design: 301 consecutive cases of biopsy-proven LN were retrospectively identified at our institution from 1998 -2014 and categorized by ISN/RPS criteria. Patients biopsied
